The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung ...

Data from the ongoing Phase 2 of EO4010 demonstrate tumor target specific immune responses and objective tumor responses, including in liver ...

The FDA has approved the drug durvalumab for adults with limited-stage small-cell lung cancer (LS-SCLC) whose disease hasn’t gotten worse after getting platinum-based chemo and radiation at the same ...

Brain cancer originates ... Early warning signs can be subtle and easily attributed to other causes, including chemotherapy, says Jonathan Goldman, MD, a clinical instructor of hematology and ...

Scientists in the United Kingdom have created a world-first urine test that could indicate the first possible signs of lung ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Scientists have created a world-first urine test which could indicate the first possible signs of lung cancer ... Early ...

The majority of cases of lung cancers are diagnosed at later stages, meaning the disease can be harder to treat ...

Cape Cod Healthcare will participate in a new national clinical research study focused on early detection of lung cancer with ...

Lung cancer innovations are not only extending lives but also enhancing the quality of life for patients, offering renewed ...

AstraZeneca’s IMFINZI ® (durvalumab) has been approved in the US for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed following ...

Cape Cod Healthcare will participate in a new national clinical research study focused on early detection of lung cancer with ...